ProShare Advisors
PGEN icon

ProShare Advisors’s Precigen PGEN Stock Holding History

ProShare Advisors’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$211K Sell
36,974
-4,987
-12% -$21.6K ﹤0.01% 1613
2026
Q1 		$162K Sell
41,961
-6,705
-14% -$27.5K ﹤0.01% 1633
2025
Q4 		$203K Buy
48,666
+12,399
+34% +$48K ﹤0.01% 1710
2025
Q3 		$119K Sell
36,267
-5,518
-13% -$15.6K ﹤0.01% 1812
2025
Q2 		$59.3K Sell
41,785
-597
-1% -$848 ﹤0.01% 1972
2025
Q1 		$63.1K Sell
42,382
-9,440
-18% -$14.9K ﹤0.01% 1922
2024
Q4 		$58K Buy
51,822
+10,900
+27% +$9.3K ﹤0.01% 2160
2024
Q3 		$38.8K Buy
40,922
+7,707
+23% +$9.72K ﹤0.01% 2005
2024
Q2 		$52.5K Sell
33,215
-7,881
-19% -$11.4K ﹤0.01% 1744
2024
Q1 		$59.6K Buy
41,096
+2,827
+7% +$4.06K ﹤0.01% 1884
2023
Q4 		$51.3K Buy
38,269
+4,014
+12% +$4.72K ﹤0.01% 1859
2023
Q3 		$48.6K Buy
34,255
+151
+0.4% +$214 ﹤0.01% 1718
2023
Q2 		$39.2K Buy
34,104
+2,344
+7% +$2.77K ﹤0.01% 1792
2023
Q1 		$33.7K Buy
31,760
+1,557
+5% +$2.25K ﹤0.01% 1707
2022
Q4 		$45.9K Buy
30,203
+1,566
+5% +$2.69K ﹤0.01% 1746
2022
Q3 		$61K Buy
28,637
+1,124
+4% +$2.37K ﹤0.01% 1638
2022
Q2 		$37K Sell
27,513
-11,664
-30% -$17.3K ﹤0.01% 1736
2022
Q1 		$83K Sell
39,177
-10,624
-21% -$25.9K ﹤0.01% 2067
2021
Q4 		$185K Sell
49,801
-6,497
-12% -$28K ﹤0.01% 2061
2021
Q3 		$281K Sell
56,298
-5,378
-9% -$31K ﹤0.01% 1594
2021
Q2 		$402K Buy
61,676
+14,990
+32% +$105K ﹤0.01% 1690
2021
Q1 		$322K Buy
46,686
+3,393
+8% +$28.7K ﹤0.01% 1763
2020
Q4 		$442K Buy
43,293
+7,407
+21% +$48K ﹤0.01% 1346
2020
Q3 		$126K Sell
35,886
-494
-1% -$2.35K ﹤0.01% 1500
2020
Q2 		$182K Buy
36,380
+9,722
+36% +$33.1K ﹤0.01% 1484
2020
Q1 		$91K Sell
26,658
-18,365
-41% -$79.3K ﹤0.01% 1085
2019
Q4 		$247K Sell
45,023
-7,023
-13% -$39.5K ﹤0.01% 1459
2019
Q3 		$298K Sell
52,046
-4,389
-8% -$29.8K ﹤0.01% 1236
2019
Q2 		$432K Sell
56,435
-1,077
-2% -$5.8K ﹤0.01% 1072
2019
Q1 		$303K Buy
57,512
+1,156
+2% +$8.01K ﹤0.01% 1254
2018
Q4 		$369K Buy
56,356
+44,834
+389% +$502K ﹤0.01% 1049
2018
Q3 		$198K Buy
11,522
+771
+7% +$11.5K ﹤0.01% 1606
2018
Q2 		$150K Buy
+10,751
New +$182K ﹤0.01% 1671
2015
Q2 		– Sell
-7,647
Closed -$332K – 1746
2015
Q1 		$332K Sell
7,647
-362
-5% -$13K ﹤0.01% 1407
2014
Q4 		$211K Sell
8,009
-6,810
-46% -$149K ﹤0.01% 1716
2014
Q3 		$263K Sell
14,819
-3,354
-18% -$68.5K ﹤0.01% 1804
2014
Q2 		$436K Buy
18,173
+5,984
+49% +$121K 0.01% 1671
2014
Q1 		$306K Buy
+12,189
New +$337K ﹤0.01% 2226

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ProShare Advisors's PGEN Position: Q2 2026 in Review

ProShare Advisors reduced its Precigen (PGEN) stake by 12% in Q2 2026, selling an estimated $21.6K and leaving 36,974 shares worth $211K. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

ProShare Advisors first reported a position in PGEN in Q1 2014 and has held it in 38 quarters since. The position peaked at $442K in Q4 2020. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • ProShare Advisors held 36,974 shares of Precigen worth $211K as of Q2 2026.
  • ProShare Advisors sold 4,987 Precigen shares in Q2 2026, an estimated $21.6K.
  • Precigen made up ﹤0.01% of ProShare Advisors's portfolio in Q2 2026, its #1613 holding.
  • ProShare Advisors first reported a position in Precigen in Q1 2014 and has held it in 38 quarters since.
  • ProShare Advisors's Precigen position peaked at $442K in Q4 2020.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on ProShare Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.